Oxidative myofiber remodeling and increase of fattyacid oxidizing actions of PPARβ/δ in skeletalmuscle may give the expectations of specific agonists in metabolic syndrome bylimiting substrate availability for lipid synthesis and accumulation in adiposetissue and other insulin sensitive tissues. The gene discussed is PPARD; the disease is metabolic syndrome.